| Elizabeth Petrikin Miller, MD | |
|
1514 Greenlawn Rd, Paoli, PA 19301-2045 | |
| (610) 639-1494 | |
| Not Available |
| Full Name | Elizabeth Petrikin Miller |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1514 Greenlawn Rd, Paoli, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063979029 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD422848 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Petrikin Miller, MD 1514 Greenlawn Rd, Paoli, PA 19301-2045 Ph: (610) 639-1494 | Elizabeth Petrikin Miller, MD 1514 Greenlawn Rd, Paoli, PA 19301-2045 Ph: (610) 639-1494 |
News Archive
Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has issued a positive opinion for RELISTOR (methylnaltrexone bromide) subcutaneous injection in pre-filled syringes.
Researchers examined heart risk factors in family members of cardiac patients and found that those who provided all or most of a patient's care had higher levels of risk factors for heart disease than non-caregivers and those who reported higher caregiver strain after six months were more likely to be depressed than those who provided less or no care.
In addition the technique to grow the blood vessels in a 3D scaffold cuts down on the risk of transplant rejection because it uses cells from the patient. It was developed by researchers from the University of Bath's Department of Pharmacy and Pharmacology, working with colleagues at Bristol Heart Institute.
In a study examining disparities and trends in the inclusion of minorities, women, and older patients in cancer clinical trials, investigators found that certain populations remain under-represented.
Scientists at Duke University Medical Center have identified a new growth factor that stimulates the expansion and regeneration of hematopoietic (blood-forming) stem cells in culture and in laboratory animals. The discovery, appearing in the journal Nature Medicine, may help researchers overcome one of the most frustrating barriers to cellular therapy: the fact that stem cells are so few in number and so stubbornly resistant to expansion.
› Verified 9 days ago
Edwin Camiel, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1440 Russell Rd, Paoli, PA 19301 Phone: 610-644-6464 | |
Craig Joseph Gardner, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11 Industrial Blvd Ste 204, Paoli, PA 19301 Phone: 610-644-6251 Fax: 610-644-1440 | |
Sumeet Singh Multani, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 255 W Lancaster Ave, Paoli, PA 19301 Phone: 484-527-2229 Fax: 484-527-0155 | |
Matthew James Viereck, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 255 W Lancaster Ave Ste 124, Paoli, PA 19301 Phone: 610-648-0553 | |
Michael Edmond Theriault, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 21 Industrial Blvd, Paoli, PA 19301 Phone: 610-647-8000 | |
Dr. Haeng Ko, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1440 Russell Rd, Paoli, PA 19301 Phone: 610-644-6464 |